Financhill
Back

Kinsale Capital Group, Inc. Vs. Novo Nordisk A/S Industry Stock Comparison

Sell
16

KNSL
Kinsale Capital Group, Inc.

Last Price:
$345.07
Seasonality Move:
14.02%
Sell
27

NVO
Novo Nordisk A/S

Last Price:
$36.97
Seasonality Move:
12.55%
Sell
16
Kinsale Capital Group, Inc. (KNSL) is a Sell

Is Kinsale Capital Group, Inc. a Buy, Sell or Hold?

  • The current Kinsale Capital Group, Inc. [KNSL] share price is $344.90. The Score for KNSL is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • KNSL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Novo Nordisk A/S (NVO) is a Sell

Is Novo Nordisk A/S a Buy, Sell or Hold?

  • The current Novo Nordisk A/S [NVO] share price is $36.98. The Score for NVO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KNSL Stock Price Chart

What is Kinsale Capital Group, Inc.'s stock price today?

  • The Kinsale Capital Group, Inc. share price today is $344.90
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSL is experiencing slight selling pressure.

NVO Stock Price Chart

What is Novo Nordisk A/S's stock price today?

  • The Novo Nordisk A/S share price today is $36.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing buying pressure, which is a positive indicator for future bullish movement.

KNSL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -10.27 Sell
Relative Strength Index (14 RSI): 44.64 Sell
Chaikin Money Flow: -37006 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (332.2 - 375.88) Sell
Bollinger Bands (100): (358.93 - 402.43) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.87 Sell
Relative Strength Index (14 RSI): 39.83 Sell
Chaikin Money Flow: 14566902 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.41 - 38.59) Sell
Bollinger Bands (100): (39.84 - 55.48) Sell

KNSL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 335.67 Buy
20-day SMA: 345.51 Sell
50-day SMA: 372.65 Sell
200-day SMA: 415.86 Sell
8-day EMA: 339.88 Buy
20-day EMA: 347.06 Sell
50-day EMA: 364.84 Sell
200-day EMA: 403.7 Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.4 Buy
20-day SMA: 37.4 Sell
50-day SMA: 44.19 Sell
200-day SMA: 53.09 Sell
8-day EMA: 36.61 Buy
20-day EMA: 37.8 Sell
50-day EMA: 42.18 Sell
200-day EMA: 54.43 Sell

Kinsale Capital Group, Inc. Earnings Growth & KNSL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.11 per share, an increase this year of $1.41 per share, and an increase next year of $1.88 per share.

Novo Nordisk A/S Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.29 per share, and an increase next year of $0.05 per share.

Kinsale Capital Group, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk A/S Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):